Vanda Pharmaceuticals Secures FDA Approval for NEREUS (Tradipitant), First New Motion Sickness Drug in Over 40 Years
Vanda Pharmaceuticals; FDA approval; NEREUS; tradipitant; motion sickness; vomiting prevention
FDA Rejects Relacorilant for Cushing’s Syndrome High Blood Pressure
FDA; relacorilant; Cushing’s syndrome; Corcept Therapeutics; rejection; high blood pressure
AbbVie Partners with China’s Zelgen on DLL3-Targeted T-Cell Engager ZG006 in Up-to-$1.2B Deal
AbbVie; Zelgen; ZG006; Alveltamig; DLL3; T-cell engager; small cell lung cancer; licensing deal
Insilico Medicine Caps 2025 with Record HKD 2.277 Billion Hong Kong IPO
Insilico Medicine; Hong Kong IPO; AI biotech; HKEX listing; drug discovery
FDA Policy Tracker: 2025 Was a Year of Change
FDA; 2025; Trump Administration; Food Safety; FSMA 204; GRAS Reform; Drug Approvals; Recall Improvements
Innovative Solutions for Difficult-to-Express Proteins: Cell-Free Systems and AI-Driven Advances
cell-free protein expression; difficult-to-express proteins; AI protein design; in vitro expression; alternative proteins
Avicanna Announces Changes to its Board of Directors
Avicanna; board changes; Michael Kott; Paul Fornazzari; appointment; resignation
US Commits $480-487 Million in Health Funding to Ivory Coast Under ‘America First’ Health Strategy
US Ivory Coast health agreement; America First health deals; $487 million funding; HIV malaria tuberculosis; global health security
Lunit SCOPE AI Achieves High Concordance in HER2 Assessment for Biliary Tract Cancer
Lunit SCOPE; HER2; biliary tract cancer; AI pathology; concordance; pathologists
Novo Nordisk Wins FDA Approval for First Oral GLP-1 Wegovy Pill in Obesity Treatment
Novo Nordisk; Wegovy pill; FDA approval; oral semaglutide; obesity treatment; GLP-1